ICLR

bearish track record →

ClearBridge exits ICLR amid healthcare, AI worries

Watch: Monitor the Audit Committee's final investigation report for clarity on revenue recognition and potential valuation impact.

Full analysis

ClearBridge Mid Cap Strategy sold its ICLR position in Q1 2026, citing healthcare weakness and AI disruption in drug development. ICLR closed at $106.81 on April 10 after a 9.43% one-month gain but a 27.21% 52-week loss. This contrasts a recent Jefferies upgrade amid ongoing internal probe risks.

ClearBridge exiting highlights investor caution over healthcare sector headwinds and unresolved accounting issues, increasing ICLR's risk profile.

Compare

vs NVDA vs AMD vs AAPL vs TSLA vs MSFT vs META vs GOOGL vs AMZN vs TSM vs ASML

Evidence

2d ago Clearbridge Mid Cap Strategy Sold ICON Public Limited Company (ICLR) in Q1 yahoo-finance

20d ago Spotify initiated, Qualcomm downgraded: Wall Street's top analyst calls yahoo-finance

36d ago Polen Global Growth Strategy Sold ICON plc (ICLR) Due to Short-Term Growth Challenges yahoo-finance

41d ago Jefferies Upgrades ICON Public Limited Company (ICLR) to Buy from Hold yahoo-finance

4 signals · latest 2d ago

Get alerted when ICLR changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →